Thompson Matthew 4
4 · Vivos Therapeutics, Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4
Thompson Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20$2.38/sh+4,000$9,520→ 7,067 totalExercise: $2.38Exp: 2029-06-20→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]On June 20, 2024, the Reporting Person received a grant of 4,000 stock options from the Issuer. One-half vested immediately, one-fourth will vest on September 30, 2024 and one-fourth will vest on December 31, 2024.